Browsing Tag
Illuccix
2 posts
Telix Pharmaceuticals (ASX: TLX) jumps 16% after CMS greenlight and Illuccix’s European rollout
Telix Pharmaceuticals raises FY25 revenue guidance after securing CMS reimbursement for Gozellix and accelerating Illuccix's launch in Europe. Learn what’s next.
Telix Pharmaceuticals gains U.S. Medicare reimbursement code for Gozellix prostate cancer imaging agent
Telix Pharmaceuticals’ Gozellix secures U.S. reimbursement code, opening access to PSMA-PET prostate cancer imaging. Find out what’s next for its rollout and impact.